单核转录组图谱的轨道前皮层在肌缩性侧面硬化症与基于深度学习的解码的替代多基化机制的替代性多基化机制
bioRxiv : the preprint server for biology
|January 8, 2024
概括
肌缩侧面硬化症 (ALS) 和前叶退化症 (FTLD) 具有共同的疾病谱. 这项研究揭示了ALS/FTLD细胞类型的特定变化,突出了神经元的改变,并为了解这些神经退行性疾病提供了资源.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 肌缩侧面硬化 (ALS) 和前叶退化 (FTLD) 是致命的,与年龄相关的神经退行性疾病在一个共享的频谱.
- 了解神经元和质细胞中的细胞类型特定变化对于阐明ALS-FTLD病理生理学至关重要.
- 轨道前皮质是ALS-FTLD中受到影响的关键大脑区域.
研究的目的:
- 在C9orf72相关和零星ALS病例的轨道前皮层中绘制细胞类型特定的转录特征.
- 确定导致ALS-FTLD的疾病和细胞类型特定的转录变化.
- 研究替代多基化 (APA) 作为ALS-FTLD的调节机制.
主要方法:
- 从ALS和FTLD患者的轨道前皮层的单核RNA测序 (snRNA-seq).
- 用来自不同皮层区域的独立数据集进行比较分析.
- 开发APA-Net,一个深度学习模型,以分析APA事件.
主要成果:
- 神经元显示出最显著的转录性改变,影响了线粒体功能,蛋白质稳态和染色质重塑.
- 在大脑区域和疾病亚型中观察到神经元STMN2和NEFL的持续上调.
- 发现APA事件与基因表达变化没有相关性,但显示了APA-Net识别的细胞类型特定调节模式.
结论:
- 这项研究提供了ALS/FTLD病理机制的细胞类型特定地图.
- 神经元功能障碍是ALS-FTLD的一个关键特征,确定了特定的分子通路.
- 这些发现为未来对ALS-FTLD治疗的研究提供了宝贵的资源.
相关概念视频
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Nucleosome Remodeling
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Long-patch Base Excision Repair
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:


